Anti-HER2 immunoliposomes for targeted therapy of human tumors

Cancer Letters

Volumn 118, Issue 2, 1997, Pages 153-160

  Park, John W ^a,b   Hong, Keelung ^a   Kirpotin, Dmitri B ^a   Meyer, Olivier ^a   Papahadjopoulos, Demetrios ^a   Benz, Christopher C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Box 1270 ^*  (United States)

Author keywords

c erbB 2; Gene therapy; HER2; Immunoliposomes; Liposomes; neu

Indexed keywords

DOXORUBICIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOLIPOSOME; LIPID; OLIGONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST TUMOR; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG STABILITY; DRUG TARGETING; DRUG TUMOR LEVEL; GENE THERAPY; GENETIC TRANSFECTION; INTERNALIZATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; REPORTER GENE; TARGET CELL; TUMOR LOCALIZATION; TUMOR XENOGRAFT;

ANTIBODIES, MONOCLONAL; DNA; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNOTHERAPY; PROTEOLIPIDS; RECEPTOR, ERBB-2; TUMOR CELLS, CULTURED;

EID: 0030778998     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00326-1     Document Type: Article

References (18)

1. J.W. Park, K. Hong, D.B. Kirpotin, D. Papahadjopoulos, C.C. Benz, Immunoliposomes for cancer treatment, in: J.T. August, J.T. Coyle, Gene Therapy, Advances in Pharmacology Vol. 40 Academic Press, San Diego, CA, 1997, pp. 399-435.
2. N.E. Hynes, D.F. Stern, The biology of erbB-2/neu/HER-2 and its role in cancer, Biochim. Biophys. Acta 1198 (1994) 165-184.
3. G.D. Lewis, I. Figari, B. Fendly, W.L. Wong, P. Carter, C. Gorman, H.M. Shepard, Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies, Cancer Immunol. Immunother. 37 (1993) 255-263.
4. H.M. Shepard, G.D. Lewis, J.C. Sarup, B.M. Fendly, D. Maneval, J. Mordenti, I. Figari, C.E. Kotts, M.A. Palladino, A. Ullrich, D. Slamon, Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic, J. Clin. Immunol. 11 (1991) 117-127.
5. HER2 monoclonal antibody in patients with HER/ nue-overexpressing metastatic breast cancer, J. Clin. Oncol. 14 (1996) 737-744.
6. M. Pegram, A. Lipton, R. Pietras, D. Hayes, B. Weber, J. Baselga, D. Tripathy, T. Twaddell, J. Glaspy, D. Slamon, Phase II study of intravenous recombinant humanized anti-p185 HER-2 monoclonal antibody (rhuMAb HER-2) plus cisplatin in patients with HER-2/neu overexpressing metastatic breast cancer, Proc. Am. Soc. Clin. Oncol. 14 (1995) 106.
7. D. Papahadjopoulos, T.M. Allen, A. Gabizon, E. Mayhew, K. Matthay, S.K. Huang, K.D. Lee, M.C. Woodle, D.D. Lasic, C. Redemann, F.J. Martin, Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy, Proc. Natl. Acad. Sci. USA 88 (1991) 11460-11464.
8. S.K. Huang, E.M. Mayhew, S. Gilani, D.D. Lasic, F.J. Martin, D. Papahadjopoulos, Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma, Cancer Res. 52 (1992) 6774-6781.
9. D.D. Lasic, F.J. Martin, Stealth Liposomes, CRC Press, Boca Raton, FL, 1995.
10. J.W. Park, K. Hong, P. Carter, H. Asgari, L.Y. Guo, G.A. Keller, C. Wirth, R. Shalaby, C. Kotts, W.I. Wood, D. Papahadjopoulos, C.C. Benz, Development of anti-p185HER2 immunoliposomes for cancer therapy, Proc. Natl. Acad. Sci. USA 92 (1995) 1327-1331.
11. D. Kirpotin, J.W. Park, K. Hong, S. Zalipsky, W.L. Li, P. Carter, C.C. Benz, D. Papahadjopoulos, Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cell in vitro, Biochemistry 36 (1997) 66-75.
12. R.P. O'Connell, P. Carter, L. Presta, C. Eigenbrot, M. Covarrubias, B. Snedecor, R. Speckart, G. Blank, D. Vetterlein, C. Kotts, Characterization of humanized anti-p185HER2 antibody Fab fragments produced in E. coli, in: J.L. Cleland (Ed.), Protein Folding In Vivo and In Vitro, American Chemical Society, Washington, DC, 1993, pp. 218-239.
13. J.W. Park, G. Colbern, J. Baselga, K. Hong, Y. Shao, D. Kirpotin, A. Nuijens, W. Wood, D. Papahadjopoulos, C. Benz, Antitumor efficacy of anti-p185HER2 immunoliposomes: enhanced therapeutic index due to targeted delivery, Proc. Am. Soc. Clin. Oncol. 15 (1996) 501.
14. S.K. Huang, K.D. Lee, K. Hong, D.S. Friend, D. Papahadjopoulos, Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res. 52 (1992) 5135-5143.
15. H.B. Muss, A.D. Thor, D.A. Berry, T. Kute, E.T. Liu, F. Koerner, C.T. Cirrincione, D.R. Budman, W.C. Wood, M. Barcos, I.C. Henderson, c-erbB-2 expression and response to adjuvant chemotherapy in women with node-positive early breast cancer, N. Engl. J. Med. 330 (1994) 1260-1266.
16. M.F. Press, C. Cordon-Cardo, D.J. Slamon, Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues, Oncogene 5 (1990) 953-962.
17. J. Baselga, L. Norton, R. Shalaby, J. Mendelsohn, Anti-HER2 humanized monoclonal antibody (MAb) alone and in combination with chemotherapy against breast carcinoma xenografts, Proc. Am. Soc. Clin. Oncol. 13 (1994) 63.
18. K. Hong, W. Zheng, A. Baker, D. Papahadjopoulos, Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery, FEBS Lett. 400 (1997) 233-237.